According to the TCGA Pan Cancer database (https://www.cbioportal.org/), the mutation rate of HSPB1 in breast cancer patients is about 0.4%, which is lower than that of some classical indicators such as TP53. This evidence concerns the gene HSPB1 and breast cancer.